Revance Therapeutics Inc. buy RudolfL
Start price
04.02.24
/
0%
€4.86
Target price
04.02.25
-
Performance (%)
13.17%
End price
04.03.24
€5.50
Summary
This prediction ended on 04.03.24 with a price of €5.50. The prediction had a final performance of 13.17%. This prediction was marked as speculative and is excluded from RudolfL's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 1,60 % | 5,04 % | 3,87 % |
| iShares Nasdaq 100 | 3,74 % | 14,95 % | 36,14 % |
| iShares Nikkei 225® | 3,74 % | 13,89 % | 43,81 % |
| iShares S&P 500 | 1,82 % | 8,88 % | 25,51 % |
Comments by RudolfL for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Buy Revance Therapeutics Inc.